Asymchem / AsymBio
Morrisville, NC (US HQ); Tianjin, China (primary manufacturing)
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (2)
○ EMA GMP
○ MHRA GMP
Quick Facts: Asymchem / AsymBio
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Morrisville, NC (US HQ); Tianjin, China (primary manufacturing)
- Modalities
- Glycan GMP synthesis, Glyco-remodeling ADC conjugation (GlycoConnect, GlycoT, DisacLink, iGDC platforms), Oligonucleotide, Small Molecule API, Peptide, ADC / Bioconjugates, Flow chemistry
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Asymchem / AsymBio
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesGlycan GMP synthesis, Glyco-remodeling ADC conjugation (GlycoConnect, GlycoT, DisacLink, iGDC platforms), Oligonucleotide, Small Molecule API, Peptide, ADC / Bioconjugates, Flow chemistry
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (7 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press2 articles
Broad modality coverage (7 modalities)
Recent News 2 articles
AsymBio Showcases Comprehensive Conjugation Toolbox to - GlobeNewswire
AsymBio Commences Commercial Operations at Fengxian Base, Strengthening Global Biopharmaceutical CDMO Capabilities - PR Newswire
Frequently Asked Questions About Asymchem / AsymBio
What is Asymchem / AsymBio's CDMO Signal Score?
Asymchem / AsymBio has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Asymchem / AsymBio for a manufacturing program?
Use the free AI matchmaker to compare Asymchem / AsymBio against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Veranova
Devens, MA
Small Molecule API, HPAPI, ADC payload/linker, Oligonucleotide, Peptide
EUROAPI
Paris, France
Small Molecule API, Microbial Fermentation API, Oligonucleotide, Peptide, HPAPI
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 85.6
Oligonucleotide, Biologics, AAV
Bachem
Bubendorf, CH
Signal Score: 83.5
Oligonucleotide
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 82.5
mRNA, Oligonucleotide, Biologics